The compensatory response to hyperglycemia seemed to overwrite the effect of inflammatory milieu characterized by hsCRP in T2D, whereas inflammation might be the main driving force of compensatory kallistatin production in nondiabetic subjects. The gene discussed is SERPINA4; the disease is type 2 diabetes mellitus.